A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
Recruiting now · Phase 1 · Has a placebo group
Conditions studied: Hepatitis B Virus Infection
In brief
The primary purpose of this study is to assess the safety and tolerability of single and multiple intravenous (IV) doses of GIGA-2339 in participants with chronic Hepatitis B Virus (HBV) infection.
Key facts
- Study ID
- NCT07024641
- Run by
- GigaGen, Inc.
- People needed
- 48
- Starts
- 2024-11-13
- Expected to finish
- 2028-11-01
- Last updated by the study team
- 2026-07-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Grifols Investigate Site — Concord, New South Wales, Australia (enrolling)
- Grifols Investigative site — Hong Kong, Hong Kong Island, Hong Kong (enrolling)
- Grifols Investigative site — Shatin, New Territories, Hong Kong (enrolling)
- Grifols Investigative site — Seogu, Busan, South Korea (enrolling)
- Grifols Investigative site — Songpa-dong, Seoul, South Korea (enrolling)
- Grifols Investigative site — Sanmin, Kaohsiung, Taiwan (enrolling)
- Grifols Investigative site — Chandler, Arizona, United States (enrolling)
- Grifols Investigative site — Huntington Beach, California, United States (enrolling)
- Grifols Investigative site — Lake Forest, California, United States (enrolling)
- Grifols Investigative site — Long Beach, California, United States (enrolling)
- Grifols Investigative site — Fortitude Valley, Queensland, Australia (enrolling)
- Grifols Investigative Site — Peachtree Corners, Georgia, United States (enrolling)
- Grifols Investigative Site — Iowa City, Iowa, United States (enrolling)
- Grifols Investigative Site — Lenexa, Kansas, United States (enrolling)
- Grifols Investigative site — Baltimore, Maryland, United States (enrolling)
- Grifols Investigative site — San Antonio, Texas, United States (enrolling)
- Grifols Investigative site — Webster, Texas, United States (enrolling)
- Grifols Investigative site — Richmond, Virginia, United States (enrolling)
- Grifols Investigative site — Oakland, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.